MedTrace Logo

Immediate Release Versus Slow Release Carvedilol in Heart Failure

NCT03209180 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2017-07-06

No results posted yet for this study

Summary

Assessment of clinical effect and treatment quality of immediate release carvedilol (IR) versus slow release carvedilol (SR) in patients with HFrEF

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

DRUG

CarVeDilol-SR (Slow Release)

patients will receive slow-release carvedilol (SR) once daily

DRUG

Carvedilol IR (Immediate Release)

patients will receive immediate release carvedilol (IR) twice daily

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical Corp.

    collaborator INDUSTRY

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-27
Primary Completion
2018-06-25
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209180 on ClinicalTrials.gov